Photo of Yuan-Feng Lin

View Scopus Profile

Yuan-Feng Lin

Associate Professor

 https://orcid.org/0000-0003-4456-0766
  • 475 Citations
  • 14 h-Index
20012020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • 2007 Ph.D. Graduate Institute of Pharmacognosy, Taipei Medical University
  • 1999 M.S., School of Pharmacy, College of Medicine, Taipei Medical University
  • 1993-1997 B.S., Department of Medical Laboratory Science and Biotechnology, Taipei Medical University

Experience

  • 2018.02- Associate Professor, Graduate Institute of Clinical Medicine, Taipei Medical University
  • 2018.02- Professor, International Master/Ph.D. Program in Medicine, College of Medicine, Taipei Medical University 
  • 2018.01-2014.07 Postdoctoral Researcher, Institute of Biological Chemistry, Academia Sinica
  • 2014.09-2018.01 Assistant Professor, Graduate Institute of Clinical Medicine, Taipei Medical University

Awards

  • 2015 Visiting Scholars, Genomics Research Center, Academia Sinica, Taiwan
  • 2015 Reviewer for PLoS one
  • 2008, 2009 and 2013 Reviewer for Journal of Cellular Biochemistry

Research Interests

  • Cancer Drug Discovery
  • Protein-Protein Interaction

URL

Fingerprint Dive into the research topics where Yuan-Feng Lin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Utilizing Artificial Intelligence Vi Rtual Screening Platform to Identify a Small-Molecule Inhibitor of Dna Polymerase Theta and Estimating Its Therapeutic Effectiveness on Metastatic Castration-Resistant Prostate Cancer

Lin, Y.

8/1/19 → 7/31/20

Project: A - Government Institution › b - Ministry of Science and Technology

探討NEDD8促進口腔癌細胞之放射線療法抗性的分子機轉

Lin, Y.

3/1/19 → 2/1/20

Project: C - Project of Alliance › n - Yuan's General Hospital

Identifying Gαh-Coupled Receptor and Studying on Its Translational Application in Triple-Negative Breast Cancer

Lin, Y.

8/1/18 → 7/1/19

Project: A - Government Institution › b - Ministry of Science and Technology

探討阻斷Galpha-h與PLC-delta1蛋白質交互作用對抗三陰性乳癌的抗藥性及轉移之機制和轉譯醫學應用(3/3)

Lin, Y.

8/1/17 → 7/31/18

Project: A - Government Institution › b - Ministry of Science and Technology

Studying on the Mechanism and Translational Application of Blocking the Protein-Protein Interaction between Galpha-h and PLC-delta1 in Combating Drug-Resistance and Metastasis of Triple-Negative Breast Cancer

Lin, Y.

8/1/16 → 7/31/17

Project: A - Government Institution › b - Ministry of Science and Technology

Research Output

  • 475 Citations
  • 14 h-Index
  • 41 Article

Association of rs2651899 Polymorphism in the Positive Regulatory Domain 16 and Common Migraine Subtypes: A Meta-Analysis

Lee, H. H., Chen, C. C., Ong, J. R., Lin, Y. F., Lee, F. P., Hu, C. J. & Wang, Y. H., Jan 1 2020, In : Headache. 60, 1, p. 71-80 10 p.

Research output: Contribution to journal › Article

    • Clinical Risk Factors for Therapeutic Lithium-Associated Electrocardiographic Changes in Patients With Bipolar Disorder

    Chen, P. H., Kao, Y. H., Chang, C. K., Lin, Y. K., Lin, Y. F. & Chen, Y. J., Jan 1 2020, In : Journal of Clinical Psychopharmacology. 40, 1, p. 46-53 8 p.

    Research output: Contribution to journal › Article

    • Histone 2A family member j drives mesenchymal transition and temozolomide resistance in glioblastoma multiforme

    Lee, H. H., Lin, C. H., Lin, H. Y., Kuei, C. H., Zheng, J. Q., Wang, Y. H., Lu, L. S., Lee, F. P., Hu, C. J., Wu, D. & Lin, Y. F., Jan 2020, In : Cancers. 12, 1, 98.

    Research output: Contribution to journal › Article

    Open Access

    • Lactotransferrin downregulation drives the metastatic progression in clear cell renal cell carcinoma

    Chiu, I. J., Hsu, Y. H., Chang, J. S., Yang, J. C., Chiu, H. W. & Lin, Y. F., Apr 2020, In : Cancers. 12, 4, 847.

    Research output: Contribution to journal › Article

    Open Access

    • Adenylate kinase 4 modulates oxidative stress and stabilizes HIF-1α to drive lung adenocarcinoma metastasis

    Jan, Y. H., Lai, T. C., Yang, C. J., Lin, Y. F., Huang, M. S. & Hsiao, M., Jan 29 2019, In : Journal of Hematology and Oncology. 12, 1, 12.

    Research output: Contribution to journal › Article

    • 5 Citations (Scopus)